MONTRÉAL, May 27, 2024 /CNW/ - Novartis Pharmaceuticals Canada Inc. is pleased to announce a partnership with Clarius Mobile Health (Clarius) as part of a dedicated effort to aid in early detection of psoriatic arthritis in Canada. By improving access to ultrasound technology, rheumatologists will be able to identify diagnostic markers sooner, and may positively impact the timeline to diagnosis for PsA patients.
Read more at newswire.caNOVARTIS CANADA AND CLARIUS MOBILE HEALTH CHALLENGE STANDARD OF CARE FOR PSORIATIC ARTHRITIS WITH NEW PARTNERSHIP
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here